New TB vaccine promising in early clinical trials
Last Updated: 2004-10-25 15:59:52 -0400 (Reuters Health)
By Megan Rauscher
NEW YORK (Reuters Health) - The results of the first early test of a new type of tuberculosis vaccine show that it elicits strong immune responses in adults with or without a previous bacille Calmette-Guerin (BCG) vaccination.
Dr. Helen McShane, from the Centre for Clinical Vaccinology and Tropical Medicine at the University of Oxford in the UK, and colleagues report the study results in the journal Nature Medicine.
Article from Reuters